Skip to Content

Kovanaze FDA Approval History

FDA Approved: Yes (First approved June 29, 2016)
Brand name: Kovanaze
Generic name: oxymetazoline hydrochloride and tetracaine hydrochloride
Dosage form: Nasal Spray
Company: St. Renatus LLC
Treatment for: Local Anesthesia

Kovanaze (oxymetazoline hydrochloride and tetracaine hydrochloride) is a vasoconstrictor and local anesthetic combination administered intranasally as a topical anesthetic for use in restorative dental procedures.

Development Timeline for Kovanaze

Jul 12, 2016Approval St. Renatus, LLC Announces FDA Approval of Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray for Use in Dentistry

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.